Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kaye Edward M. MD, Director. Director active across 5 companies, notably Cytokinetics INC. Cumulatively, 63 reports have been recorded. Split: 0 buy · 15 sells. Total volume traded: €3.6m. Activity tracked since 12 May 2021. The latest transaction was filed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kaye Edward M. MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
328 shares@ US$38.018.7% of flowCommon StockSEC:0001127602-25-019288:0
25 of 63 declarations
About Kaye Edward M. MD
Kaye Edward M. MD is Administrateur. He has filed 59 filings in total, and in the sampled recent filings the transactions run from 2016-01-25 to 2026-06-01, with EUR 0 of buys and EUR 3266448 of sales. The largest recent filings concern Stoke Therapeutics, Inc. and CYTOKINETICS INC.